We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-3.05%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$52.7B
AUM Growth
-$2.48B
(-4.5%)
Cap. Flow
+$256M
Cap. Flow
% of AUM
0.49%
Top 10 Holdings %
Top 10 Hldgs %
16.27%
Holding
2,367
New
187
Increased
1,008
Reduced
966
Closed
158
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$237M |
| 2 |
Pfizer
PFE
|
+$200M |
| 3 |
Moderna
MRNA
|
+$143M |
| 4 |
EPAM Systems
EPAM
|
+$106M |
| 5 |
Gilead Sciences
GILD
|
+$94.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$138M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$135M |
| 3 |
AngloGold Ashanti
AU
|
+$112M |
| 4 |
Costco
COST
|
+$111M |
| 5 |
Microsoft
MSFT
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.94% |
| 2 | Healthcare | 15.7% |
| 3 | Industrials | 11.74% |
| 4 | Financials | 11.69% |
| 5 | Consumer Discretionary | 10.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
NRG Energy
NRG
$25B
| $140M | 0.27% |
3,641,372
+709,192
| +24% | +$27.6M |
|
77
CVS Health
CVS
$122B
| $139M | 0.26% |
1,374,070
+105,598
| +8% | +$11.1M |
|
78
Eaton
ETN
$173B
| $139M | 0.26% |
913,550
-89,381
| -9% | -$14M |
|
79
Nucor
NUE
$62.5B
| $138M | 0.26% |
929,805
+460,380
| +98% | +$56.5M |
|
80
Duke Energy
DUK
$94.5B
| $138M | 0.26% |
1,233,718
+227,872
| +23% | +$23.7M |
|
81
Colgate-Palmolive
CL
$74.3B
| $137M | 0.26% |
1,811,513
+23,017
| +1% | +$1.82M |
|
82
International Paper
IP
$21.9B
| $136M | 0.26% |
2,950,157
+554,771
| +23% | +$25.5M |
|
|
83
Target
TGT
$69B
| $136M | 0.26% |
640,295
-635,936
| -50% | -$138M |
|
84
Expeditors International
EXPD
$23.3B
| $135M | 0.26% |
1,312,664
-154,468
| -11% | -$17M |
|
85
Steel Dynamics
STLD
$38.5B
| $135M | 0.26% |
1,621,670
+452,125
| +39% | +$30.5M |
|
86
Mettler-Toledo International
MTD
$28.6B
| $134M | 0.25% |
97,373
-12,191
| -11% | -$17.6M |
|
87
Zoetis
ZTS
$30.9B
| $134M | 0.25% |
708,049
-27,574
| -4% | -$5.45M |
|
88
McKesson
MCK
$103B
| $133M | 0.25% |
433,785
-217,539
| -33% | -$59.2M |
|
89
LyondellBasell Industries
LYB
$20.2B
| $133M | 0.25% |
1,290,903
+397,434
| +44% | +$39.6M |
|
90
Wells Fargo
WFC
$265B
| $132M | 0.25% |
2,730,284
+973,283
| +55% | +$52.1M |
|
91
Medtronic
MDT
$114B
| $132M | 0.25% |
1,189,695
-177,515
| -13% | -$18.8M |
|
92
Nike
NKE
$62.5B
| $130M | 0.25% |
968,119
-270,730
| -22% | -$38M |
|
93
O'Reilly Automotive
ORLY
$75.3B
| $130M | 0.25% |
2,844,810
-588,690
| -17% | -$26.3M |
|
94
Vertex Pharmaceuticals
VRTX
$133B
| $129M | 0.24% |
499,944
-98,539
| -16% | -$23.4M |
|
95
Consolidated Edison
ED
$39.3B
| $127M | 0.24% |
1,342,608
+547,691
| +69% | +$47.3M |
|
96
Qualcomm
QCOM
$170B
| $127M | 0.24% |
828,429
+64,630
| +8% | +$10.8M |
|
97
Citigroup
C
$227B
| $123M | 0.23% |
2,309,637
+567,411
| +33% | +$35M |
|
98
McDonald's
MCD
$194B
| $121M | 0.23% |
488,739
+2,185
| +0.4% | +$544K |
|
99
Labcorp
LH
$26.1B
| $117M | 0.22% |
517,544
+21,071
| +4% | +$4.96M |
|
100
3M
MMM
$93.9B
| $117M | 0.22% |
939,420
-465,184
| -33% | -$61.9M |
|
Similar funds
VGA
AQR Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, AQR Capital Management held 2,367 positions worth $52.7B, down 4.5% from $55.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
AQR Capital Management's Q1 2022 filing shows 187 new, 1,008 increased, 966 reduced and 158 closed positions. Its largest new stake was Carnival Corporation Ltd: 1,737,168 shares worth $34.8M. The largest sale was Target, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.
- AQR Capital Management's largest Q1 2022 buy was Carnival Corporation Ltd: 1,737,168 shares worth $34.8M.
- AQR Capital Management added most to Meta Platforms (Facebook) in Q1 2022, an estimated $237M increase.
- AQR Capital Management's biggest Q1 2022 reduction was Target, cutting an estimated $138M.
- AQR Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $25.4M.
- AQR Capital Management's ten largest holdings make up 16% of its $52.7B portfolio in Q1 2022.
- AQR Capital Management opened 187 new positions and closed 158 in Q1 2022.
- AQR Capital Management's portfolio value fell 4.5% quarter-over-quarter to $52.7B.
Based on AQR Capital Management's 13F filing for Q1 2022, filed 16 May 2022.